logo
NEW SKIN
RENAL CANCER IN RENAL TRANSPLANT PAEDIATRIC RECIPIENTS
TARGETING GENE THERAPY FOR TRANSPLANTATION WITH VENOM
USE OF EMBRYONIC HUMAN TRACHEA GROWN IN NUDE MICE TO PATCH-REPAIR CONGENITAL TRACHEAL STENOSIS1
NUCLEAR FACTOR-κB TRANSCRIPTION FACTOR DECOY TREATMENT INHIBITS GRAFT CORONARY ARTERY DISEASE AFTER CARDIAC TRANSPLANTATION IN RODENTS1
PROTECTION OF AUTOTRANSPLANTED PIG KIDNEYS FROM ISCHEMIA-REPERFUSION INJURY BY POLYETHYLENE GLYCOL1
MONITORING OF INTRAGRAFT PRESSURE OF REJECTING ORGANS
PREDICTIVE FACTORS FOR PORTAL FIBROSIS IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS
LONG-TERM REGENERATION OF HUMAN EPIDERMIS ON THIRD DEGREE BURNS TRANSPLANTED WITH AUTOLOGOUS CULTURED EPITHELIUM GROWN ON A FIBRIN MATRIX1,2
INCREASED ALVEOLAR MACROPHAGE NUCLEAR FACTOR-κ B ACTIVATION AND MACROPHAGE INHIBITORY PROTEIN-1α LEVELS IN LUNG TRANSPLANT PATIENTS
OUTFLOW TRACT RECONSTRUCTION IN LIVING DONOR LIVER TRANSPLANTATION1
NEUTROPHIL DYSPLASIA CAUSED BY MYCOPHENOLATE MOFETIL
NITRIC OXIDE PRODUCTION AND NITRIC OXIDE SYNTHASE EXPRESSION IN ACUTE HUMAN RENAL ALLOGRAFT REJECTION1
EFFICIENT GENE DELIVERY TO VASCULAR SMOOTH MUSCLE CELLS USING A NONTOXIC, SYNTHETIC PEPTIDE VECTOR SYSTEM TARGETED TO MEMBRANE INTEGRINS: A FIRST STEP TOWARD THE GENE THERAPY OF CHRONIC REJECTION1
COLD ISCHEMIA IN THE ABSENCE OF ALLOREACTIVITY INDUCES CHRONIC TRANSPLANT NEPHROPATHY THROUGH A PROCESS MEDIATED BY THE PLATELET-ACTIVATING FACTOR1
IMMUNOMODULATION FOR INTESTINAL TRANSPLANTATION BY ALLOGRAFT IRRADIATION, ADJUNCT DONOR BONE MARROW INFUSION, OR BOTH1
ISLET ALLOGRAFT REJECTION CAN BE MEDIATED BY CD4+, ALLOANTIGEN EXPERIENCED, DIRECT PATHWAY T CELLS OF TH1 AND TH2 CYTOKINE PHENOTYPE1
DEVELOPMENT OF RENAL CELL CARCINOMA IN LIVING DONOR KIDNEY GRAFTS
INDUCIBLE EXPRESSION OF BASIC TRANSCRIPTION FACTOR-BINDING PROTEIN 2 (BTEB2), A MEMBER OF ZINC FINGER FAMILY OF TRANSCRIPTION FACTORS, IN CARDIAC ALLOGRAFT VASCULAR DISEASE1
ANNOUNCEMENTS